Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

To determine the relation between the presence of donor DNA polymerase and e antigen, and recipient hepatitis, we tested, under code, serums from a controlled trial of hepatitis B immune globulin used to treat individuals accidentally inoculated with HBs Ag-positive blood. All recipients lacked antibody to HBs Ag. In 29 of 31 donors, both polymerase and e were in perfect agreement; both demonstrated a highly significant correlation with recipient hepatitis (P less than 0.001). DNA polymerase/e-negative blood did not cause hepatitis. Blood containing polymerase or e antigen did not cause hepatitis in six of 31 and four of 18 recipients, respectively. Hepatitis did not correlate with transaminase or duration of antigenemia in the donor. Polymerase and e appear to be indicators of the relative infectivity of HBs Ag-positive serum, particularly after small-volume exposure. They may be important determinants in assessing infectivity of chronic carriers of HBs Ag and in evaluating efficacy of hepatitis B immune globulin and hepatitis B vaccines.

[1]  F. Tsuda,et al.  Association of dane particles with e antigen in the serum of asymptomatic carriers of hepatitis B surface antigen. , 1976, Journal of immunology.

[2]  M. Imai,et al.  e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. , 1976, The New England journal of medicine.

[3]  R. Purcell,et al.  Demonstration of subpopulations of Dane particles , 1976, Journal of virology.

[4]  R. Purcell,et al.  Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus. , 1975, The American journal of pathology.

[5]  W. Szmuness.  Recent advances in the study of the epidemiology of hepatitis B. , 1975, The American journal of pathology.

[6]  H. Greenlee,et al.  EFFICACY OF HEPATITIS B IMMUNE SERUM GLOBULIN AFTER ACCIDENTAL EXPOSURE Preliminary Report of the Veterans Administration Cooperative Study , 1975, The Lancet.

[7]  M. Březina,et al.  Letter: e Antigen in HBs Ag-carrier mothers. , 1975, The New England journal of medicine.

[8]  R. Purcell,et al.  Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. , 1975, The American journal of the medical sciences.

[9]  P. Hung,et al.  Rolling circular DNA associated with Dane particles in hepatitis B virus , 1975, Nature.

[10]  J. Nielsen,et al.  Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme. , 1974, Lancet.

[11]  R. Greenman,et al.  DNA of a Human Hepatitis B Virus Candidate , 1974, Journal of virology.

[12]  J. Gerin,et al.  Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis , 1974, Nature.

[13]  J. Hoofnagle,et al.  Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. , 1974, The New England journal of medicine.

[14]  R. Greenman,et al.  DNA Polymerase in the Core of the Human Hepatitis B Virus Candidate , 1974, Journal of virology.

[15]  R. Greenman,et al.  DNA Polymerase Associated with Human Hepatitis B Antigen , 1973, Journal of virology.

[16]  J. Mosley,et al.  Factors influencing neonatal infection by hepatitis B virus. , 1973, Gastroenterology.

[17]  S. Sherlock,et al.  Spread of acute type-B hepatitis in London. , 1973, Lancet.

[18]  S. Krugman,et al.  Viral hepatitis, type B (MS-2-strain). Further observations on natural history and prevention. , 1973, The New England journal of medicine.

[19]  W. Pelon,et al.  Identification of a type B hepatitis epidemic in Costa Rica. Comparative analysis of two outbreaks of viral hepatitis. , 1972, American journal of epidemiology.

[20]  Magnius Lo,et al.  New Specificities in Australia Antigen Positive Sera Distinct from the Le Bouvier Determinants , 1972 .

[21]  Redeker Ag,et al.  Increased anti-HBAg titers after administration of human protein solutions. , 1972 .

[22]  H. Bond,et al.  Separation and purification of hepatitis-associated antigen into morphologic types by zonal ultracentrifugation. , 1972, The Journal of infectious diseases.

[23]  D. S. Dane,et al.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. , 1970, Lancet.

[24]  H. Greenberg,et al.  Hepatitis antigen. Detection of infectious blood donors. , 1969, Lancet.

[25]  E. Nordenfelt,et al.  Dane particles, DNA polymerase, and e-antigen in two different categories of hepatitis B antigen carriers. , 1975, Intervirology.